SCHEMBL12542012

SCHEMBL12542012

COc1ccc(C(=O)C=Cc2ccc(OCc3ccccc3)cc2OCc2ccccc2)c(OC)c1C

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.58
APP P05067 3/20 0.52
ALOX5 P09917 2/20 0.51
MAPT P10636 4/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MEN1 O00255 1/20 0.50
MAPK1 P28482 1/20 0.50
KMT2A Q03164 1/20 0.50
PTPN1 P18031 1/20 0.49
PDE4A P27815 2/20 0.48
PDE4B Q07343 2/20 0.48
PDE4C Q08493 2/20 0.48
PDE4D Q08499 2/20 0.48
ALDH1A1 P00352 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CHRNA7 P36544 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12542009 1.00 HDAC8 (0.58) HDAC8APPALOX5MAPTNPC1
SCHEMBL12541737 0.93 ALOX5 (0.56) HDAC8APPALOX5MAPTNPC1
SCHEMBL12541741 0.93 ALOX5 (0.56) HDAC8APPALOX5MAPTNPC1
SCHEMBL22754637 0.91 HDAC8 (0.57) HDAC8APPALOX5MAPTNPC1
SCHEMBL12695487 0.91 HDAC8 (0.51) HDAC8APPPDE4APDE4BPDE4C
SCHEMBL7751091 0.85 HDAC8 (0.62) HDAC8APPMAPTNPC1RAB9A
SCHEMBL7751094 0.85 HDAC8 (0.62) HDAC8APPMAPTNPC1RAB9A
SCHEMBL12695565 0.85 CHRNA7 (0.50) HDAC8APPALOX5MAPTPTPN1
SCHEMBL22754654 0.84 APP (0.57) HDAC8APPALOX5MAPTNPC1
SCHEMBL8682788 0.84 HDAC8 (0.75) HDAC8APPMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3822246-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES Unigen, Inc. (US) 2021-05-19 EP disclosed
EP-2688860-B1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES UNIGEN INC (US) 2020-12-09 EP disclosed
US-20160096795-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES UNIGEN INC (US) 2016-04-07 US disclosed
US-9045405-B2 Compounds and methods for preparation of diarylpropanes UNIGEN, INC. (US) 2015-06-02 US disclosed
US-20140235899-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES UNIGEN, INC. (US) 2014-08-21 US disclosed
EP-2688860-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES Unigen, Inc. (US) 2014-01-29 EP disclosed
US-8586799-B2 Compounds and methods for preparation of diarylpropanes UNIGEN, INC. (US) 2013-11-19 US disclosed
US-20120245393-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES UNIGEN, INC. (US) 2012-09-27 US disclosed
WO-2012129260-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES UNIGEN, INC. (US) 2012-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160096795-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES DDT, QDPR, NPY1R HDAC8 1660/4885APP 195/4885ALOX5 1646/4885
US-20120245393-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES DDT, QDPR, NPY1R HDAC8 1660/4885APP 195/4885ALOX5 1646/4885
US-20140235899-A1 COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES DDT, QDPR, NPY1R HDAC8 1660/4885APP 195/4885ALOX5 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.